WuXi AppTec - About the company
WuXi AppTec is a public company based in Shanghai (China), founded in 2000. It operates as a Provider of CRO and CDMO services. WuXi AppTec has raised $40M in funding. The company has 1071 active competitors, including 70 funded and 128 that have exited. Its top competitors include companies like ANI Pharmaceuticals, EVERSANA and Ipsen.
Company Details
WuXi AppTec is a provider of a suite of CRO and CDMO services for small molecules, biologics, and medical devices. It offers a suite of services for the research, development, and manufacturing of both small molecules and biologics and also caters to medical device development and has operations all over the globe. They provide a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. The company built its initial capabilities around discovery chemistry and has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, DMPK/ADME, discovery biology, pharmacology, formulation, toxicology, genomic services, biologics manufacturing services, antibody, and biological research reagent manufacturing and sales, and most recently clinical research and regulatory services. In 2022, the company recorded annual revenues of $5.84B and a net profit of $1.31B.
- Website
- wuxiapptec.com
- Registered Address
- Saint Paul, Minnesota
Key Metrics
Founded Year
2000
Location
Shanghai, China
Stage
Public
Total Funding
$40M in 5 rounds
Latest Funding Round
Ranked
1st among 1071 active competitors
Annual Revenue
£1M - £10M as on Dec 31, 2024
Employee Count
4,155 as on Nov 16, 2025
Similar Companies
Exit Details
Public
Legal entities associated with WuXi AppTec
WuXi AppTec is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
WUXI APP TEC, INC. CIN: 300135172 , United States, Active | Dec 31, 1999 | - | 1733 (As on Dec 31, 2024) | - |
WUXI APPTEC UK LTD CIN: 7495313 , United Kingdom, Active | Jan 16, 2011 | £1M - £10M (As on Dec 31, 2024) | 33 (As on Dec 31, 2024) |
WuXi AppTec's IPO details
WuXi AppTec got listed on Dec 14, 2018.
Click here to take a look at WuXi AppTec's IPO in detail
Sign up to download WuXi AppTec's company profile
WuXi AppTec's funding and investors
WuXi AppTec has raised a total funding of $40M over 5 rounds. Its first funding round was on Feb 2007. Its latest funding round was a Post IPO round on Apr 02, 2021 for $*****. 1 investor participated in its latest round. WuXi AppTec has 29 institutional investors.
Here is the list of recent funding rounds of WuXi AppTec:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 02, 2021 | 5925366 | Post IPO | 7876689 | 5318181 | 8764866 | 7265044 |
Aug 24, 2020 | 8591586 | Post IPO | 7424201 | 5177667 | 9012657 | 7032385 |
Mar 02, 2016 | 8031000 | Conventional Debt | 9901896 | 9141000 | 6499185 |
View details of WuXi AppTec's funding rounds and investors
WuXi AppTec's founders and board of directors
Founder? Claim ProfileWuXi AppTec's employee count trend
WuXi AppTec has 4,155 employees as of Nov 25. Here is WuXi AppTec's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
WuXi AppTec's Competitors and alternates
Top competitors of WuXi AppTec include ANI Pharmaceuticals, EVERSANA and Ipsen. Here is the list of Top 10 competitors of WuXi AppTec, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | WuXi AppTec 2000, Shanghai (China), Public | Provider of CRO and CDMO services | $40M | 79/100 | |
2nd | ANI Pharmaceuticals 1996, Baudette (United States), Public | Manufacturer of pharmaceutical products, including extended-release capsules and immediate-release tablets | - | 64/100 | |
3rd | EVERSANA 2014, Milwaukee (United States), Funding Raised | Provider of consulting services for drug pricing access, reimbursement, and regulatory support | - | 63/100 | |
4th | Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | - | 62/100 | ||
5th | Zuellig Pharma 1992, Singapore (Singapore), Funding Raised | Provider of clinical research, quality management, logistics, and clinical trial supply services | - | 61/100 | |
6th | Eurofins Scientific 1987, Luxembourg (Luxembourg), Public | Provider of laboratory testing services and CRO contract research services | - | 61/100 | |
7th | Precision Medicine Group 2012, Bethesda (United States), Late Stage | Provider of clinical research, development, and commercialization services for life sciences | $532M | 60/100 | |
8th | Curatio healthcare 2005, Chennai (India), Acquired | Provider of market research services for biopharma sector, and dermatology products for cosmetologists | $44.8M | 59/100 | |
9th | China Medical System 1992, Shenzhen (China), Public | Manufacturer of generic formulations | - | 55/100 | |
10th | Provider of regulatory, clinical trials and analytic services | - | 55/100 |
Looking for more details on WuXi AppTec's competitors? Click here to see the top ones
WuXi AppTec's Investments and acquisitions
WuXi AppTec has made 39 investments in companies including D3 Bio and Structure. WuXi AppTec has also acquired 2 companies including Mingjie Pharmaceutical and Pharmapace.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Apr 08, 2024 | Investments | 2018 | Shanghai (China) | |
Oct 20, 2021 | Investments | 2017 | San Francisco (United States) | |
Jun 03, 2021 | Investments | 2016 | Pudong (China) |
See all investments and acquisitions by WuXi AppTec
News related to WuXi AppTec
Media has covered WuXi AppTec for a total of 24 events in the last 1 year, 5 of them have been about company updates.
•
WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive YearMiningstockeducation•Jul 22, 2026•WuXi AppTec
•
•
WuXi AppTec Recognized on 2026 Dow Jones Best-in-Class World IndexPR Newswire•May 18, 2026•WuXi AppTec
•
•
WuXi AppTec Delivers Strong Revenue and Profit Growth in Q1 2026PR Newswire•Apr 27, 2026•WuXi AppTec
•
WuXi AppTec Beat Full-Year Guidance and Achieved Record Performance in 2025PR Newswire•Mar 23, 2026•WuXi AppTec
•
•
D3 Bio Secures $108 Million in Series B Financing to Advance Global Clinical ProgramsPR Newswire•Dec 10, 2025•Temasek, IDG Capital, D3 Bio, HSG and 5 others
•
Pentagon Eyes Adding WuXi AppTec to Military List, Creating UncertaintyEndpoints•Dec 03, 2025•WuXi AppTec
•
Are you a Founder ?
FAQs about WuXi AppTec
Explore our recently published companies
- Autocal - Thane based, 2002 founded, Funding Raised company
- Indo Amines - Thane based, 1994 founded, Public company
- Taro International - Haifa based, 1992 founded, Unfunded company
- SmartCart AI - San Francisco based, Unfunded company
- 365 Retail Markets - London based, 2008 founded, Unfunded company
- Bishop Paiute Development Corporation - Bishop based, 2009 founded, Funding Raised company